Does Blue Cross Blue Shield Cover Forteo?
The verdict
Conditional on most plans
BCBS plans broadly cover teriparatide for severe osteoporosis, but brand Forteo is frequently non-preferred compared to generic teriparatide injection or Bonsity, and the specific formulary status varies across 30-plus independent BCBS licensees. Prior authorization and documented bisphosphonate trial and failure are required. Verify brand Forteo's status on your specific state BCBS formulary — the answer varies by licensee and PBM.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield using your member ID.
Key facts
Brand Forteo is frequently non-preferred on BCBS formularies — generic teriparatide injection and Bonsity are the preferred alternatives, reflecting the industry-wide shift to lower-cost generics.
BCBS licensee formularies; industry formulary data
Teriparatide is approved for a maximum of 24 months of lifetime use — PA approval periods of 12–24 months reflect this limit.
FDA Forteo prescribing information; Eli Lilly
BCBS is 30-plus independent licensees; Forteo's formulary tier, PBM, and step-therapy sequence vary by state plan — there is no single national BCBS policy.
BCBS Association / state licensee formularies
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield covers Forteo depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D (BCBS MA-PD plans): teriparatide is covered on the specialty tier with PA; brand Forteo is often non-preferred versus generic teriparatide or Bonsity. Coinsurance is typically 25–33% after the deductible, capped at $2,100 for the year under the 2026 Part D out-of-pocket limit. Manufacturer savings cards are not available to Medicare beneficiaries. Step-therapy and brand-versus-generic preferred-drug status vary by BCBS licensee and their Medicare PBM — verify on your specific BCBS MA-PD or Part D plan.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: teriparatide is covered on the specialty tier with PA and step therapy; brand Forteo is frequently non-preferred, with generic teriparatide injection or Bonsity preferred. This reflects the industry-wide pattern of insurers and PBMs moving to lower-cost generics when available. Tier, PBM, and preferred-drug status vary across 30-plus BCBS licensees — common PBMs include Prime Therapeutics, CVS Caremark, and Express Scripts. Verify on your state BCBS formulary. Manufacturer copay support may apply to brand Forteo for commercially insured patients if approved. ACA/Individual: teriparatide covered with PA where offered; brand often non-preferred. Medicaid (BCBS-managed): teriparatide covered per state PDL preferred-drug status with PA; nominal cost-share.
The 5 boxes you must tick to get approved
Commercial plans that will consider Forteo require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Forteo actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Brand Forteo is a high-cost specialty drug (list price in the several-thousand-dollar-per-month range — estimate; verify with pharmacy). Generic teriparatide injection and Bonsity are lower-cost preferred alternatives — check GoodRx or your BCBS formulary for generic pricing.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: specialty coinsurance per BCBS licensee; manufacturer copay support may apply to brand Forteo for commercially insured if approved. Medicare Part D: typically 25–33% coinsurance after the deductible, capped at $2,100 for the year (2026 cap). Medicaid: per state PDL preferred-drug status; nominal cost-share. Savings cards are not available to Medicare or Medicaid beneficiaries.
Typical monthly copay once prior authorization is approved.
Bridge program
Brand Forteo may have manufacturer copay assistance for eligible commercially insured patients (Eli Lilly patient support). Not available for Medicare or Medicaid. Visit forteo.com to check eligibility. Generic teriparatide manufacturers may also offer savings programs — ask your specialty pharmacist.
Reduced copay through the assistance program, where eligible.
Brand Forteo is often not the covered option at BCBS — confirm whether your state BCBS plan covers brand or generic teriparatide before filling. All figures are estimates; verify with your state BCBS plan or PBM.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Find your specific state BCBS formulary
There is no single national BCBS Forteo policy — each of the 30-plus licensees sets its own formulary. Go to your state BCBS plan website (e.g., bcbsil.com, bcbsnc.com, independencebcbs.com) and use the drug or formulary lookup tool to search for 'teriparatide' and 'Forteo' separately to see whether brand is covered, non-preferred, or excluded on your plan.
- 2
Confirm bisphosphonate step-therapy documentation with your prescriber
Before initiating the PA, verify with your prescribing physician that your bisphosphonate trial and failure is documented — including which drug was tried, the dose, the duration, and the reason for discontinuation (lack of efficacy, contraindication, or side effects). This documentation is the key step-therapy requirement for teriparatide approval.
- 3
Have your prescriber submit the PA through your state BCBS plan
Ask your prescribing physician (endocrinologist, rheumatologist, or bone-density specialist) to submit the PA through your specific state BCBS plan. If requesting brand Forteo over the preferred generic, the prescriber must document a specific clinical reason. The PA will route through your licensee's PBM and specialty pharmacy — confirm the approved specialty pharmacy with your plan.
Options if Blue Cross Blue Shield won't cover Forteo
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Generic teriparatide injection
The FDA-approved generic form of Forteo is the most likely covered alternative on BCBS formularies. It contains the same active ingredient at the same dose. Ask your prescriber whether the generic is clinically appropriate — it is the default approval path on most BCBS plans.
Bonsity (teriparatide, Teva)
A branded generic teriparatide (Teva) that may be preferred or co-listed with the unbranded generic on some BCBS licensee formularies. Check your state BCBS drug list for its tier relative to brand Forteo and generic teriparatide.
Abaloparatide (Tymlos)
Another anabolic bone agent (PTHrP analog) approved for severe osteoporosis. May carry a different formulary tier than brand Forteo on your BCBS plan. Verify on your state BCBS formulary.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Often not as the preferred option. Brand Forteo is frequently non-preferred on BCBS formularies across commercial, Medicare, and Medicaid lines, with generic teriparatide injection or Bonsity as the preferred alternative. This varies by state licensee and PBM — some plans may cover brand Forteo with PA and documented medical necessity; others exclude it entirely. Verify on your specific state BCBS formulary. Verifying brand versus generic status before prescribing saves time in the PA process.
Most BCBS licensees require documented trial and failure of at least one bisphosphonate — such as alendronate, risedronate, or zoledronic acid — due to lack of efficacy, contraindication, or intolerable side effects. This reflects teriparatide's role as a second-line anabolic agent for patients who cannot tolerate antiresorptive therapy. Your prescriber must document the specific bisphosphonate tried and the reason for discontinuation in the PA submission.
Yes, teriparatide is covered on the specialty tier via BCBS Medicare Advantage or Part D plans, but brand Forteo is often non-preferred. Coinsurance is typically 25–33% after the deductible, capped at $2,100 for the year under the 2026 Part D cap. Manufacturer savings cards are not available to Medicare beneficiaries. The preferred formulary option is likely generic teriparatide — verify on your specific BCBS MA-PD or Part D plan.
The contrast is sharp. BCBS Prolia is a medical-benefit drug — a clinician-administered injection every 6 months billed under the medical benefit (Medicare Part B buy-and-bill for most Medicare members) — and it is broadly covered for approved osteoporosis indications. Brand Forteo is a pharmacy-benefit self-injected daily drug that is frequently non-preferred or excluded on BCBS formularies. Both treat osteoporosis, but they are on opposite benefit rails with very different coverage outcomes.
No. BCBS is 30-plus independent licensees, each with its own formulary, PBM, and step-therapy rules. Brand Forteo's preferred-drug status, tier placement, and step-therapy sequence differ by state plan and its PBM (Prime Therapeutics, CVS Caremark, Express Scripts, or others). Some licensees may cover brand Forteo on the specialty tier with PA; others may exclude it entirely. Always verify on your specific state BCBS formulary — there is no single national BCBS Forteo policy.
Related Articles
Does BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Ambien? 2026 | Curex
Blue Cross Blue Shield covers generic zolpidem (Tier 1–2); brand Ambien is non-preferred. Quantity limits apply. Verify your specific BCBS plan for 2026.
Read moreDoes BCBS of Texas Cover Ozempic? 2026 Guide | Curex
BCBS Texas (HCSC) covers Ozempic for T2D with PA — not weight loss. HCSC shares PA with BCBS IL. TX Medicaid uses separate Star MCOs. Verify on BCBS TX.
Read moreThis content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation.